PROMIS Neuropathic and Nociceptive Pain Quality in Musculoskeletal Pain Presentations.

Vaughan, B; Chase, B; Hickey, J; Tassoulas, M; Weston, H; Fitzgerald, K; Fleischmann, M; Mulcahy, J; Austin, P

PROMIS Neuropathic and Nociceptive Pain Quality in Musculoskeletal Pain Presentations.

Vaughan, B

Chase, B Hickey, J Tassoulas, M Weston, H Fitzgerald, K Fleischmann, M Mulcahy, J Austin, P

Permalink

Publisher:: Lippincott, Williams & Wilkins
Publication Type:: Journal Article
Citation:: Clinical Journal of Pain, 2021, 37, (9), pp. 639-647
Issue Date:: 2021-09

Closed Access

	Filename	Description	Size
	PROMIS Neuropathic and Nociceptive Pain Quality in Musculoskeletal Pain Presentations.pdf		247.6 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Vaughan, B https://orcid.org/0000-0002-8623-4558
dc.contributor.author	Chase, B
dc.contributor.author	Hickey, J
dc.contributor.author	Tassoulas, M
dc.contributor.author	Weston, H
dc.contributor.author	Fitzgerald, K
dc.contributor.author	Fleischmann, M
dc.contributor.author	Mulcahy, J
dc.contributor.author	Austin, P
dc.date.accessioned	2021-12-13T01:27:01Z
dc.date.available	2021-06-09
dc.date.available	2021-12-13T01:27:01Z
dc.date.issued	2021-09
dc.identifier.citation	Clinical Journal of Pain, 2021, 37, (9), pp. 639-647
dc.identifier.issn	0749-8047
dc.identifier.issn	1536-5409
dc.identifier.uri	http://hdl.handle.net/10453/152267
dc.description.abstract	Objective: Musculoskeletal pain is a significant contributor to the global disease burden. Management of musculoskeletal pain where a neuropathic component is present can be challenging. This study evaluated the internal structure of the Patient-Reported Outcome Measures Information System (PROMIS) pain quality scales, explored the prevalence of neuropathic and nociceptive pain, and identified health demographics and behaviors related to musculoskeletal pain presentations. Methods: Patients presenting to the Victoria University Osteopathy Clinic (Melbourne, Vic., Australia) were invited to complete a health demographics and behaviors questionnaire, and the PROMIS Neuropathic (NeuroPQ) and Nociceptive (NociPQ) pain quality scales, before their initial consultation. Descriptive, inferential, and correlation statistics were used to evaluate the PROMIS scales, health demographics, and behaviors. Mokken scale analysis was used to evaluate the internal structure and dimensionality of the NeuroPQ and NociPQ scales. Results: Three hundred eighty-three (N=383) patients completed the measures. Mokken scaling suggested the PROMIS scales demonstrated acceptable internal structure and were unidimensional. Over 22% of patients demonstrated cutoff scores above 50, suggesting a substantive neuropathic pain component to their musculoskeletal presentation. Patients who reported cigarette smoking, not being born in Australia or not speaking English at home, demonstrated higher NeuroPQ scores. Females demonstrated significantly higher NociPQ scores than males. Pain intensity demonstrated small to medium correlations with NeuroPQ and NociPQ scores. Discussion: This study provides support for the use of the NeuroPQ and NociPQ scales in musculoskeletal pain patients. Associations with health demographics and behaviors were identified, and patients typically experienced a combination of neuropathic and nociceptive pain.
dc.format	Print
dc.language	eng
dc.publisher	Lippincott, Williams & Wilkins
dc.relation.ispartof	Clinical Journal of Pain
dc.relation.isbasedon	10.1097/ajp.0000000000000955
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	1103 Clinical Sciences, 1109 Neurosciences
dc.subject.classification	Anesthesiology
dc.subject.mesh	Female
dc.subject.mesh	Humans
dc.subject.mesh	Information Systems
dc.subject.mesh	Male
dc.subject.mesh	Musculoskeletal Pain
dc.subject.mesh	Nociceptive Pain
dc.subject.mesh	Patient Reported Outcome Measures
dc.subject.mesh	Surveys and Questionnaires
dc.subject.mesh	Humans
dc.subject.mesh	Information Systems
dc.subject.mesh	Female
dc.subject.mesh	Male
dc.subject.mesh	Nociceptive Pain
dc.subject.mesh	Musculoskeletal Pain
dc.subject.mesh	Surveys and Questionnaires
dc.subject.mesh	Patient Reported Outcome Measures
dc.subject.mesh	Female
dc.subject.mesh	Humans
dc.subject.mesh	Information Systems
dc.subject.mesh	Male
dc.subject.mesh	Musculoskeletal Pain
dc.subject.mesh	Nociceptive Pain
dc.subject.mesh	Patient Reported Outcome Measures
dc.subject.mesh	Surveys and Questionnaires
dc.title	PROMIS Neuropathic and Nociceptive Pain Quality in Musculoskeletal Pain Presentations.
dc.type	Journal Article
utslib.citation.volume	37
utslib.location.activity	United States
utslib.for	1103 Clinical Sciences
utslib.for	1109 Neurosciences
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/Public Health
utslib.copyright.status	closed_access	*
pubs.consider-herdc	false
dc.date.updated	2021-12-13T01:27:00Z
pubs.issue	9
pubs.publication-status	Published
pubs.volume	37
utslib.citation.issue	9

Abstract:

Objective: Musculoskeletal pain is a significant contributor to the global disease burden. Management of musculoskeletal pain where a neuropathic component is present can be challenging. This study evaluated the internal structure of the Patient-Reported Outcome Measures Information System (PROMIS) pain quality scales, explored the prevalence of neuropathic and nociceptive pain, and identified health demographics and behaviors related to musculoskeletal pain presentations. Methods: Patients presenting to the Victoria University Osteopathy Clinic (Melbourne, Vic., Australia) were invited to complete a health demographics and behaviors questionnaire, and the PROMIS Neuropathic (NeuroPQ) and Nociceptive (NociPQ) pain quality scales, before their initial consultation. Descriptive, inferential, and correlation statistics were used to evaluate the PROMIS scales, health demographics, and behaviors. Mokken scale analysis was used to evaluate the internal structure and dimensionality of the NeuroPQ and NociPQ scales. Results: Three hundred eighty-three (N=383) patients completed the measures. Mokken scaling suggested the PROMIS scales demonstrated acceptable internal structure and were unidimensional. Over 22% of patients demonstrated cutoff scores above 50, suggesting a substantive neuropathic pain component to their musculoskeletal presentation. Patients who reported cigarette smoking, not being born in Australia or not speaking English at home, demonstrated higher NeuroPQ scores. Females demonstrated significantly higher NociPQ scores than males. Pain intensity demonstrated small to medium correlations with NeuroPQ and NociPQ scores. Discussion: This study provides support for the use of the NeuroPQ and NociPQ scales in musculoskeletal pain patients. Associations with health demographics and behaviors were identified, and patients typically experienced a combination of neuropathic and nociceptive pain.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/152267